keyword
https://read.qxmd.com/read/38614983/the-preliminary-analysis-of-lymphatic-flow-around-the-connective-tissues-surrounding-sma-and-spa-elucidates-patients-oncological-condition-in-borderline-resectable-pancreatic-cancer
#1
JOURNAL ARTICLE
Hirofumi Akita, Kei Asukai, Yosuke Mukai, Shinichiro Hasegawa, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Masato Sakon, Hiroshi Wada, Hidenori Takahashi
BACKGROUND: In pancreatic ductal adenocarcinoma (PDAC), invasion of connective tissues surrounding major arteries is a crucial prognostic factor after radical resection. However, why the connective tissues invasion is associated with poor prognosis is not well understood. MATERIALS AND METHODS: From 2018 to 2020, 25 patients receiving radical surgery for PDAC in our institute were enrolled. HyperEye Medical System (HEMS) was used to examine lymphatic flow from the connective tissues surrounding SMA and SpA and which lymph nodes ICG accumulated in was examined...
April 13, 2024: BMC Surgery
https://read.qxmd.com/read/38614721/trousseau-s-syndrome-with-non-bacterial-thrombotic-endocarditis-nbte-in-a-patient-with-advanced-pancreatic-cancer
#2
JOURNAL ARTICLE
Zong Xuan Lee, Joyce Oi Suet Cheng, Mohammed Tauseef Sharip, Htar Htar Hlaing, Michael Allison
No abstract text is available yet for this article.
November 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614523/-the-pre-habilitation-sessions-gave-me-confidence
#3
JOURNAL ARTICLE
Marc Vidal
Aged 45, married with two children, Marc has always lived a "healthy" lifestyle: no cigarettes, a balanced organic diet and regular exercise. He had never experienced any serious health problems until January 2023, when symptoms led him to seek medical advice. He was diagnosed with pancreatic cancer. He tells us about his journey since then.
April 2024: Soins; la Revue de Référence Infirmière
https://read.qxmd.com/read/38613802/identification-of-a-robust-biomarker-laptm4a-for-glioma-based-on-comprehensive-computational-biology-and-experimental-verification
#4
JOURNAL ARTICLE
Yongqi Ding, Yike Jiang, Hong Zeng, Minqin Zhou, Xuanrui Zhou, Zichuan Yu, Jingying Pan, Xitong Geng, Yanting Zhu, Hao Zheng, Shuhan Huang, Yiyang Gong, Huabin Huang, Chengfeng Xiong, Da Huang
BACKGROUND: Glioma, a highly invasive and deadly form of human neoplasm, presents a pressing need for the exploration of potential therapeutic targets. While the lysosomal protein transmembrane 4A (LATPM4A) has been identified as a risk factor in pancreatic cancer patients, its role in glioma remains unexplored. METHODS: The analysis of differentially expressed genes (DEG) was conducted from The Cancer Genome Atlas (TCGA) glioma dataset and the Genotype Tissue Expression (GTEx) dataset...
April 12, 2024: Aging
https://read.qxmd.com/read/38613466/molecular-pathway-of-pancreatic-cancer-associated-neuropathic-pain
#5
REVIEW
Shweta Subhash Giri, Alok Shiomurti Tripathi, Pınar Erkekoğlu, Magdi E A Zaki
The pancreas is a heterocrine gland that has both exocrine and endocrine parts. Most pancreatic cancer begins in the cells that line the ducts of the pancreas and is called pancreatic ductal adenocarcinoma (PDAC). PDAC is the most encountered pancreatic cancer type. One of the most important characteristic features of PDAC is neuropathy which is primarily due to perineural invasion (PNI). PNI develops tumor microenvironment which includes overexpression of fibroblasts cells, macrophages, as well as angiogenesis which can be responsible for neuropathy pain...
April 2024: Journal of Biochemical and Molecular Toxicology
https://read.qxmd.com/read/38613330/retrospective-review-of-the-toxicities-and-change-in-dosing-patterns-for-pegaspargase-in-patients-with-acute-lymphoblastic-leukemia-lymphoma-and-t-cell-lymphoma
#6
JOURNAL ARTICLE
Grace Baek, Miryoung Kim, Madison Lee, Shan O'Connor, Lauren Held, Lars van der Laan, Ryan D Cassaday
INTRODUCTION: Pegaspargase (PEG) is a key component of standard regimens for acute lymphoblastic leukemia/lymphoma (ALL) and extranodal natural killer/T-cell lymphoma (NKTCL). Emerging evidence suggests an opportunity to decrease incidence of PEG-associated toxicities with dose capping, but evidence is limited. This study aims to evaluate whether a significant difference in PEG-associated toxicities related to dosing strategy exists and to identify patient-specific or regimen-specific factors for PEG-related toxicity...
April 13, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38613239/ecm1-and-krt6a-are-involved-in-tumor-progression-and-chemoresistance-in-the-effect-of-dexamethasone-on-pancreatic-cancer
#7
JOURNAL ARTICLE
Yoshiki Shinomiya, Yusuke Kouchi, Sakurako Harada-Kagitani, Takayuki Ishige, Shigetsugu Takano, Masayuki Ohtsuka, Jun-Ichiro Ikeda, Takashi Kishimoto
Pancreatic ductal adenocarcinoma (PDAC) has a very poor prognosis. Neoadjuvant chemotherapy is an effective PDAC treatment option, but chemotherapy causes unfavorable side effects. Glucocorticoids (e.g., dexamethasone [DEX]) are administered to reduce side effects of chemotherapy for solid tumors, including pancreatic cancer. Glucocorticoids have both beneficial and detrimental effects, however. We investigated the functional changes and gene-expression profile alterations induced by DEX in PDAC cells. PDAC cells were treated with DEX, and the cell proliferation, migration, invasion, and chemosensitivity to gemcitabine (GEM) were evaluated...
April 13, 2024: Cancer Science
https://read.qxmd.com/read/38612768/protein-arginine-methyltransferases-in-pancreatic-ductal-adenocarcinoma-new-molecular-targets-for-therapy
#8
REVIEW
Kritisha Bhandari, Wei-Qun Ding
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignant disease with a low 5-year overall survival rate. It is the third-leading cause of cancer-related deaths in the United States. The lack of robust therapeutics, absence of effective biomarkers for early detection, and aggressive nature of the tumor contribute to the high mortality rate of PDAC. Notably, the outcomes of recent immunotherapy and targeted therapy against PDAC remain unsatisfactory, indicating the need for novel therapeutic strategies...
April 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612727/micrornas-in-pancreatic-cancer-advances-in-biomarker-discovery-and-therapeutic-implications
#9
REVIEW
Roland Madadjim, Thuy An, Juan Cui
Pancreatic cancer remains a formidable malignancy characterized by high mortality rates, primarily attributable to late-stage diagnosis and a dearth of effective therapeutic interventions. The identification of reliable biomarkers holds paramount importance in enhancing early detection, prognostic evaluation, and targeted treatment modalities. Small non-coding RNAs, particularly microRNAs, have emerged as promising candidates for pancreatic cancer biomarkers in recent years. In this review, we delve into the evolving role of cellular and circulating miRNAs, including exosomal miRNAs, in the diagnosis, prognosis, and therapeutic targeting of pancreatic cancer...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612627/the-role-of-endocrine-disruption-chemical-regulated-aryl-hydrocarbon-receptor-activity-in-the-pathogenesis-of-pancreatic-diseases-and-cancer
#10
REVIEW
Kyounghyun Kim
The aryl hydrocarbon receptor (AHR) serves as a ligand-activated transcription factor crucial for regulating fundamental cellular and molecular processes, such as xenobiotic metabolism, immune responses, and cancer development. Notably, a spectrum of endocrine-disrupting chemicals (EDCs) act as agonists or antagonists of AHR, leading to the dysregulation of pivotal cellular and molecular processes and endocrine system disruption. Accumulating evidence suggests a correlation between EDC exposure and the onset of diverse pancreatic diseases, including diabetes, pancreatitis, and pancreatic cancer...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612567/decoding-the-versatile-landscape-of-autophagic-protein-vmp1-in-cancer-a-comprehensive-review-across-tissue-types-and-regulatory-mechanisms
#11
REVIEW
Felipe J Renna, Claudio D Gonzalez, Maria I Vaccaro
Autophagy, a catabolic process orchestrating the degradation of proteins and organelles within lysosomes, is pivotal for maintaining cellular homeostasis. However, its dual role in cancer involves preventing malignant transformation while fostering progression and therapy resistance. Vacuole Membrane Protein 1 (VMP1) is an essential autophagic protein whose expression, per se, triggers autophagy, being present in the whole autophagic flux. In pancreatic cancer, VMP1-whose expression is linked to the Kirsten Rat Sarcoma Virus (KRAS) oncogene-significantly contributes to disease promotion, progression, and chemotherapy resistance...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612551/collagen-lattice-model-populated-with-heterogeneous-cancer-associated-fibroblasts-facilitates-advanced-reconstruction-of-pancreatic-cancer-microenvironment
#12
JOURNAL ARTICLE
Xiaoyu Song, Yuma Nihashi, Yukiko Imai, Nobuhito Mori, Noritaka Kagaya, Hikaru Suenaga, Kazuo Shin-Ya, Masamichi Yamamoto, Daiki Setoyama, Yuya Kunisaki, Yasuyuki S Kida
Pancreatic ductal adenocarcinoma (PDAC) is a solid-tumor malignancy. To enhance the treatment landscape of PDAC, a 3D model optimized for rigorous drug screening is essential. Within the PDAC tumor microenvironment, a dense stroma comprising a large extracellular matrix and cancer-associated fibroblasts (CAFs) is well-known for its vital role in modulating tumor growth, cellular heterogeneity, bidirectional paracrine signaling, and chemoresistance. In this study, we employed a fibroblast-populated collagen lattice (FPCL) modeling approach that has the ability to replicate fibroblast contractility in the collagenous matrix to build dense stroma...
March 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612494/adjustments-of-the-phytochemical-profile-of-broccoli-to-low-and-high-growing-temperatures-implications-for-the-bioactivity-of-its-extracts
#13
JOURNAL ARTICLE
Ivana Šola, Daria Gmižić, Marija Pinterić, Ana Tot, Jutta Ludwig-Müller
Climate change causes shifts in temperature patterns, and plants adapt their chemical content in order to survive. We compared the effect of low (LT) and high (HT) growing temperatures on the phytochemical content of broccoli ( Brassica oleracea L. convar. botrytis (L.) Alef. var. cymosa Duch.) microgreens and the bioactivity of their extracts. Using different spectrophotometric, LC-MS/MS, GC-MS, and statistical methods, we found that LT increased the total phenolics and tannins in broccoli. The total glucosinolates were also increased by LT; however, they were decreased by HT...
March 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611692/the-doppler-perfusion-index-of-the-liver-and-the-underlying-duplex-sonography-of-visceral-vessels-a-systematic-and-comprehensive-evaluation-of-reproducibility
#14
JOURNAL ARTICLE
Christian Lueders, Johannes Gladitz, Georg Bauer, Christian Jenssen, Jana Belaschki, Arndt von Kirchbach, Christoph Schneider, Thomas Kiefer, Heinz Voeller, Daniel Merkel
Prior to the curative resection of colorectal carcinoma (CRC) or pancreatic ductal adenocarcinoma (PDAC), the exclusion of hepatic metastasis using cross-sectional imaging is mandatory. The Doppler perfusion index (DPI) of the liver is a promising method for detecting occult liver metastases, but the underlying visceral duplex sonography is critically viewed in terms of its reproducibility. The aim of this study was to investigate systematically the reproducibility of the measured variables, the calculated blood flow, and the DPI...
April 8, 2024: Diagnostics
https://read.qxmd.com/read/38611638/three-dimensional-structure-of-novel-liver-cancer-biomarker-liver-cancer-specific-serine-protease-inhibitor-kazal-lc-spik-and-its-performance-in-clinical-diagnosis-of-hepatocellular-carcinoma-hcc
#15
REVIEW
Felix Lu, Connor Ott, Prabha Bista, Xuanyong Lu
LC-SPIK is a liver cancer-specific isoform of Serine Protease Inhibitor Kazal and has been proposed as a new biomarker for the detection of HCC given its unique 3D structure, which differs from normal pancreatic SPIK. An ELISA technology based on its unique structure was developed to use LC-SPIK as an effective biomarker for the clinical diagnosis of HCC. AFP, the most widely used biomarker for HCC surveillance currently, suffers from poor clinical performance, especially in the detection of early-stage HCC...
March 29, 2024: Diagnostics
https://read.qxmd.com/read/38611111/identifying-the-spatial-architecture-that-restricts-the-proximity-of-cd8-t-cells-to-tumor-cells-in-pancreatic-ductal-adenocarcinoma
#16
JOURNAL ARTICLE
Yihan Xia, Junrui Ma, Xiaobao Yang, Danping Liu, Yujie Zhu, Yanan Zhao, Xuefeng Fei, Dakang Xu, Jing Dai
The anti-tumor function of CD8+ T cells is dependent on their proximity to tumor cells. Current studies have focused on the infiltration level of CD8+ T cells in the tumor microenvironment, while further spatial information, such as spatial localization and inter-cellular communication, have not been defined. In this study, co-detection by indexing (CODEX) was designed to characterize PDAC tissue regions with seven protein markers in order to identify the spatial architecture that regulates CD8+ T cells in human pancreatic ductal adenocarcinoma (PDAC)...
April 7, 2024: Cancers
https://read.qxmd.com/read/38611098/growth-charts-for-shwachman-diamond-syndrome-at-ages-0-to-18-years
#17
JOURNAL ARTICLE
Anna Pegoraro, Valentino Bezzerri, Gloria Tridello, Cecilia Brignole, Francesca Lucca, Emily Pintani, Cesare Danesino, Simone Cesaro, Francesca Fioredda, Marco Cipolli
Shwachman-Diamond syndrome (SDS) is one of the most common inherited bone marrow failure syndromes. SDS is characterized by hypocellular bone marrow, with a severe impairment of the myeloid lineage, resulting in neutropenia, thrombocytopenia, and, more rarely, anemia. Almost 15% of patients with SDS develop myelodysplastic syndrome or acute myeloid leukemia as early as childhood or young adulthood. Exocrine pancreatic insufficiency is another common feature of SDS. Almost all patients with SDS show failure to thrive, which is associated with skeletal abnormalities due to defective ossification...
April 5, 2024: Cancers
https://read.qxmd.com/read/38611003/role-of-sglt2-inhibitors-dpp-4-inhibitors-and-metformin-in-pancreatic-cancer-prevention
#18
REVIEW
Tooba Laeeq, Maheen Ahmed, Hina Sattar, Muhammad Hamayl Zeeshan, Meher Binte Ali
Pancreatic carcinoma is a highly aggressive tumor that usually presents when it has already metastasized. Therapeutic options for cure remain scarce and rely on combination chemotherapy with limited sustainability. Diabetes is considered an important risk factor for the development of pancreatic cancer due to the production of proinflammatory cytokines, which result in increased cell proliferation. More than half of patients diagnosed with pancreatic cancer eventually develop diabetes due to the destruction of insulin-producing cells...
March 28, 2024: Cancers
https://read.qxmd.com/read/38611000/results-of-a-randomized-double-blind-placebo-controlled-phase-1b-2-trial-of-nabpaclitaxel-gemcitabine-%C3%A2-olaratumab-in-treatment-na%C3%A3-ve-participants-with-metastatic-pancreatic-cancer
#19
JOURNAL ARTICLE
Faithlore P Gardner, Zev A Wainberg, Christos Fountzilas, Nathan Bahary, Mark S Womack, Teresa Macarulla, Ignacio Garrido-Laguna, Patrick M Peterson, Erkut Borazanci, Melissa Johnson, Matteo Ceccarelli, Uwe Pelzer
The efficacy and safety of olaratumab plus nabpaclitaxel and gemcitabine in treatment-naïve participants with metastatic pancreatic ductal adenocarcinoma was evaluated. An initial phase 1b dose-escalation trial was conducted to determine the olaratumab dose for the phase 2 trial, a randomized, double-blind, placebo-controlled trial to compare overall survival (OS) in the olaratumab arm vs. placebo arms. In phase 1b, 22 participants received olaratumab at doses of 15 and 20 mg/kg with a fixed dose of nabpaclitaxel and gemcitabine...
March 28, 2024: Cancers
https://read.qxmd.com/read/38610935/could-periodontitis-increase-the-risk-of-suffering-from-pancreatic-cancer-a-systematic-review
#20
REVIEW
Cecilia Fabiana Márquez-Arrico, Francisco Javier Silvestre, Julia Elena Marquez-Arrico, Javier Silvestre-Rangil
(1) Background: The relationship between periodontitis and systemic pathologies continues to grow. Recently, the presence of periodontal pathogens has been linked to an increased risk of pancreatic cancer (PC) and its mortality. Thus, a systematic review is needed to identify whether an association between the two diseases can be established. The objective of this review is to elucidate the mechanisms responsible for this association. (2) Methods: A systematic review was carried out using three databases (PubMed, Embase and Scopus) with the following keywords "Periodontitis AND pancreatic cancer"...
March 23, 2024: Cancers
keyword
keyword
51141
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.